The Ser358Leu mutation of transmembrane protein 43 (TMEM43) was commonly identified in the patients of highly lethal and fully penetrant ARVD subtype, ARVD5. This evidence concerns the gene TMEM43 and Arrhythmogenic right ventricular dysplasia.